Skip to content
10-Q

Quarterly Report

MERRIMACK PHARMACEUTICALS INC

0000950170-23-038082

← back to feed
Filed
Aug 3, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 1, 2023 14.32M sh
Shares Diluted Q2 2023 · Jun 30, 2023 14.29M sh
Shares Diluted Q2 2023 · Jun 30, 2023 14.27M sh
Shares Diluted Q2 2023 · Jun 30, 2022 13.41M sh
Shares Diluted Q2 2023 · Jun 30, 2022 13.41M sh
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$1.02M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$1.29M
Short Term Investments Q2 2023 · Jun 30, 2023 $8.84M
Short Term Investments Q2 2023 · Dec 31, 2022 $0
Cash And Equivalents Q2 2023 · Jun 30, 2023 $10.13M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $19.44M
Stockholders Equity Q2 2023 · Jun 30, 2023 $19.04M
Stockholders Equity Q2 2023 · Mar 31, 2023 $19.17M
Stockholders Equity Q2 2023 · Dec 31, 2022 $19.25M
Stockholders Equity Q2 2023 · Jun 30, 2022 $13.61M
Stockholders Equity Q2 2023 · Mar 31, 2022 $14.08M
Stockholders Equity Q2 2023 · Dec 31, 2021 $14.19M
Current Liabilities Q2 2023 · Jun 30, 2023 $411K
Current Liabilities Q2 2023 · Dec 31, 2022 $589K
Total Liabilities Q2 2023 · Jun 30, 2023 $411K
Total Liabilities Q2 2023 · Dec 31, 2022 $589K
Current Assets Q2 2023 · Jun 30, 2023 $19.44M
Current Assets Q2 2023 · Dec 31, 2022 $19.83M
Total Assets Q2 2023 · Jun 30, 2023 $19.45M
Total Assets Q2 2023 · Dec 31, 2022 $19.84M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.03
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.05
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.04
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.05
Eps Basic Q2 2023 · Jun 30, 2023 −$0.03
Eps Basic Q2 2023 · Jun 30, 2023 −$0.05
Eps Basic Q2 2023 · Jun 30, 2022 −$0.04
Eps Basic Q2 2023 · Jun 30, 2022 −$0.05
Operating Income Q2 2023 · Jun 30, 2023 −$569K
Operating Income Q2 2023 · Jun 30, 2023 −$1.02M
Operating Income Q2 2023 · Jun 30, 2022 −$486K
Operating Income Q2 2023 · Jun 30, 2022 −$618K